succinic acid has been researched along with Neurodegenerative Diseases in 2 studies
Succinic Acid: A water-soluble, colorless crystal with an acid taste that is used as a chemical intermediate, in medicine, the manufacture of lacquers, and to make perfume esters. It is also used in foods as a sequestrant, buffer, and a neutralizing agent. (Hawley's Condensed Chemical Dictionary, 12th ed, p1099; McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed, p1851)
succinic acid : An alpha,omega-dicarboxylic acid resulting from the formal oxidation of each of the terminal methyl groups of butane to the corresponding carboxy group. It is an intermediate metabolite in the citric acid cycle.
Neurodegenerative Diseases: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rice, A | 1 |
Michaelis, ML | 1 |
Georg, G | 1 |
Liu, Y | 1 |
Turunen, B | 1 |
Audus, KL | 1 |
Burlina, AB | 1 |
Gibson, KM | 1 |
Ruitenbeek, W | 1 |
Bonafè, L | 1 |
Bennett, MJ | 1 |
2 other studies available for succinic acid and Neurodegenerative Diseases
Article | Year |
---|---|
Overcoming the blood-brain barrier to taxane delivery for neurodegenerative diseases and brain tumors.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Blood-Brain Barrier | 2003 |
Profound neurological phenotype in a patient presenting with disordered isoleucine and energy metabolism.
Topics: Acetyl-CoA C-Acyltransferase; Amino Acid Metabolism, Inborn Errors; Cells, Cultured; Dicarboxylic Ac | 1998 |